Inducible Release of TRAIL Fusion Proteins from a Proapoptotic Form for Tumor Therapy

Cancer Research

Volumn 64, Issue 9, 2004, Pages 3236-3242

  Shah, Khalid ^a   Tung, Ching Hsuan ^a   Yang, Katherine ^a   Weissleder, Ralph ^a   Breakefield, Xandra O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; FLUORESCENT DYE; HYBRID PROTEIN; PROTEINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CANCER THERAPY; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FLUORESCENCE; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN SECRETION; PROTEIN TARGETING; PROTEIN VARIANT; RAT; RECEPTOR BINDING; REPORTER GENE; TUMOR CELL DESTRUCTION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CERCOPITHECUS AETHIOPS; ENDOPEPTIDASES; ENDOPLASMIC RETICULUM; GLIOMA; HERPESVIRUS 1, HUMAN; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; RECOMBINANT FUSION PROTEINS; SPECTROSCOPY, NEAR-INFRARED; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; VERO CELLS; VIRAL PROTEINS;

EID: 2342583529     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3516     Document Type: Article

References (34)

1. Pollack IF, Erff M, Ashkenazi A. Direct stimulation of apoptotic signaling by soluble Apo21/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res 2001;7:1362-9.
2. Lee J, Hampl M, Albert P, Fine HA. Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector. Neoplasia 2002;4:312-23.
3. Shah K, Tang Y, Breakefield XO, Weissleder R. Real time imaging of TRAIL induced apoptosis of glioma tumors in vivo. Oncogene 2003;22:6865-72.
4. LeBlanc HN, Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Diff 2003;10:66-75.
5. Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett 1998;427:124-8.
6. Wajant H, Pfizemaier K, Scheurich P. TNT-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy. Apoptosis 2002;7:449-59.
7. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815-8.
8. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999;5:157-63.
9. Degli-Esposti MA, Smolak PJ, Walczak H, et al. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 1997;186:1165-70.
10. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 1997;272:25417-20.
11. Marsters SA, Sheridan JP, Pitti RM, et al. A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 1997;7:1003-6.
12. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999;11:255-60.
13. Lyman SD, James L, Vanden Bos T, et al. Molecular cloning of a ligand for the Flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993;75:1157-67.
14. Pisarev VM, Parajuli P, Mosley RL, et al. Flt3 ligand and conjugation to IL-1β peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine. Vaccine 2002;20:2358-68.
15. Wu X, He Y, Falo LD Jr, Hui KM, Huang L. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein. Mol Ther 2001;3:368-74.
16. Lynch DH, Andreason A, Maraskovsky E, Whitmore J, Miller RE, Schuh JC. Flt3 ligand induces tumor regression and anti-tumor immune responses in vivo. Nat Med 1997;3:625-31.
17. Saeld Y, Breakefield XO, Chiocca EA. Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA. In: Machida CA, editor. Viral vectors for gene therapy methods and protocols. Totowa, NJ: Humana Press; 2003. p. 51-60.
18. Darke PL, Chen E, Hall DL, et al. Purification of active herpes simplex virus-1 protease expressed in Escherichia coli. J Biol Chem 1994;269:18708-11.
19. Munro S, Pelham HR. A C-terminal signal prevents secretion of luminal ER proteins. Cell 1987;48:899-907.
20. Stephans DJ, Bantings G. Specificity of interaction between adaptor-complex medium chains and the tyrosine-based sorting motifs of TGN38 and lgp120. Biochem J 1998;335:567-72.
21. Tung C, Bredown S, Mahmood U, Weissleder R. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjugate Chem 1999;10: 892-6.
22. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-82.
23. Gliniak B, Le T. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res 1999;59:6153-8.
24. Harbury PB, Kim PS, Alber T. Crystal structure of an isoleucine-zipper trimer. Nature 1994;371:80-3.
25. Johnson TR, Stone K, Nikrad M, et al. The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. Oncogene 2003;22:4953-63.
26. Wang SH, Mezosi E, Wolf JM, et al. IFN-γ sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Oncogene. In press 2004.
27. Shah K, Tung C-H, Chang C-H, et al. In vivo imaging of HIV protease activity in T cells and amplicon vector transduced gliomas. Cancer Res 2004;64:273-8.
28. Weissleder R, Tung C, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999;17:375-8.
29. Chen J, Tung CH, Mahmood U, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002;105:2766-71.
30. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001;7:743-8.
31. Rivera VM, Wang X, Wardwell S, et al. Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum, Science 2000;287:826-30.
32. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999;13:1211-33.
33. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000;97:12846-51.
34. Wang S, Petravicz J, Breakefield XO. Single HSV-amplicon vector mediates drug-induced gene expression via dimerizer system. Mol Ther 2003;7:790-800.